Charles River Laboratories, Valo Health: drug discovery partnership
Charles River Laboratories International has announced a partnership with Valo Health, the AI-powered data solutions firm. The agreement reportedly combines Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities to offer a new AI-enabled drug discovery and development platform.
“Our collaboration with Valo is another step we’re taking toward accelerating drug discovery and development,” said Birgit Girshick, corporate executive vice president and COO of Charles River. “By leveraging disruptive, AI-powered tools like Opal, we can support our clients in more quickly progressing their discoveries to the clinic.”
